Inspire Medical Systems, Inc. (INSP)
NYSE: INSP · IEX Real-Time Price · USD
143.74
+5.92 (4.30%)
At close: Jul 19, 2024, 4:00 PM
143.69
-0.05 (-0.03%)
After-hours: Jul 20, 2024, 12:58 PM EDT
Inspire Medical Systems Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for INSP stock have an average target of 244.29, with a low estimate of 159 and a high estimate of 371. The average target predicts an increase of 69.95% from the current stock price of 143.74.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for INSP stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 4 | 4 |
| Buy | 6 | 6 | 7 | 8 | 6 | 6 |
| Hold | 3 | 3 | 3 | 3 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 15 | 16 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $280 → $217 | Strong Buy | Maintains | $280 → $217 | +50.97% | Jul 16, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $250 → $210 | Buy | Maintains | $250 → $210 | +46.10% | Jul 15, 2024 |
| Stifel | Stifel | Hold Maintains $210 → $170 | Hold | Maintains | $210 → $170 | +18.27% | Jun 24, 2024 |
| B of A Securities | B of A Securities | Hold Maintains $225 → $185 | Hold | Maintains | $225 → $185 | +28.70% | Jun 3, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $250 → $255 | Buy | Maintains | $250 → $255 | +77.40% | May 8, 2024 |
Financial Forecast
Revenue This Year
803.76M
from 624.80M
Increased by 28.64%
Revenue Next Year
970.91M
from 803.76M
Increased by 20.80%
EPS This Year
0.16
from -0.72
EPS Next Year
0.91
from 0.16
Increased by 454.48%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 833.0M | 1.0B | 1.3B | 1.5B | 1.7B |
| Avg | 803.8M | 970.9M | 1.2B | 1.4B | 1.6B |
| Low | 767.3M | 882.5M | 1.1B | 1.3B | 1.5B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 33.3% | 28.0% | 29.1% | 28.1% | 24.4% |
| Avg | 28.6% | 20.8% | 20.0% | 19.4% | 15.5% |
| Low | 22.8% | 9.8% | 9.8% | 10.2% | 5.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.21 | 2.52 | 5.58 | 4.36 | 5.47 |
| Avg | 0.16 | 0.91 | 2.40 | 3.82 | 5.07 |
| Low | 0.10 | 0.20 | 0.93 | 3.33 | 4.21 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 1,433.5% | 511.9% | 81.7% | 43.1% |
| Avg | - | 454.5% | 163.2% | 59.4% | 32.6% |
| Low | - | 19.3% | 2.2% | 39.0% | 10.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.